FDA Compliance Digest

Join the U.S. FDA and Major Pharma and Device Manufacturers who attend our events; Pfizer, Merck, Johnson & Johnson, AstraZeneca, Medtronic, Boston Scientific, Alcon, Schering-Plough, Roche, Bristol Myers Squibb, Becton Dickinson and more...

***SCHEDULE***

GLP LIVE Training Workshops - (click here for complete brochure)

Two GLP Workshops in Two Locations

1. The Brass Tacks of GLP: Practical Understanding of the Fundamentals As Never Before Explained

2. Writing Effective GLP Docments

March 9-10, 2010 San Diego

March 11-12, 2010 San Francisco by a GLP Subject Matter Expert

Medical Device Software Validation LIVE Training Workshops - (click here for complete brochure)

Two Workshops in Two Locations

1. Medical Device Software Validation: System Definition and Requirements: Incorporating Effectiveness and Compliance in Software Design

2. Implementing Critical Processes for Effectively Supporting Medical Device Software Validation Programs

March 24-25, 2010 Iselin, NJ

May 19-20, 2010 Waltham, MA by Boston Scientific

CAPA LIVE Training Workshops - (click here for complete brochure)

Two Workshops

1. CAPA: Effective System Management - One Industry Professional Shares His Expertise

2.Supplier-Related CAPA: Conducting Effective Root Cause Investigations

April 20-21, 2010 Boston/Waltham, MA

by a CAPA Subject Matter Expert

GMP LIVE Training Workshop: Master Production Batch Records - (click here for complete brochure)

Effective Generation and Control of Master Production Batch Records (MPBR)

April 22, 2010 Boston/Waltham, MA by a GMP Subject Matter Expert

GMP LIVE Training Workshop: Introduction to Drug Good Manufacturing Practice (GMP): Meeting FDA Requirements - (click here for complete brochure)

May 12-13, 2010 Hilton Woodbridge-Iselin, NJ by a GMP Subject Matter Expert

To View Previously Recorded Webinars Click Here

Special 21 CFR Part 11 Recording Package - Click Here for More Details

Recent Webinar TESTIMONIALS:

"It was the perfect presentation for my audience. Over the last year, since I started retraining all my frequent fliers, I have gone over or flagged for action every concern in that presentation. I had people in the audience that needed a final re-enforcement. I believe every "hot-topic" in Change Control was covered". - Anuja Rajbhandari, Change Control Specialist - AstraZeneca - CLICK HERE TO VIEW THE WEBINAR ON CHANGE CONTROL

"Enjoyed it. It was like the trainer has worked at our facility!!" - Carol S. Spicer, Director, Quality, Training and Support Services - Bridge Laboratories - CLICK HERE TO VIEW THE WEBINAR ON GLP DEVIATIONS

U.S. Toll Free: 877-823-4GXP

Outside the U.S. +1-561-795-2785

e-mail: info@enkap.com

1480 Royal Palm Beach Blvd.,Suite A, Royal Palm Beach, FL 33411, U.S.

enKap Terms and Conditions

All sales are final

Legal Disclaimer

This product and any of its enclosures, attachments or appendices, references to online information, conferences or preparations of materials in a variety of formats are created to provide you with accurate and authorative information concerning the subject matter covered. However, this product and any other ancillary items disseminated in connec-
tion with same are not necessarily prepared by a person licensed to practice law in a particular jurisdiction.
enKap, Inc. is not engaged in rendering legal advice, and this product is not a substitute for the advice of an attorney. If you require legal or other expert advice, you should seek
the services of a competent attorney or other professional.
enKap, Inc. necessarily is not, cannot and will not be liable for any claims, damages, or regulatory legal proceedings initiated as a consequence of you, the customer, modifying,
altering, adding to or deleting portions of any product initially provided by enKap, Inc.
Once any original document provided by enKap, Inc. to you, whether in print or electronic format, has been manipulated or customized by you, then the responsibility for the
document’s accuracy, correctness, and compliance are solely yours.
If any action, claim for damages, or regulatory proceedings is commenced against enKap, Inc. as a consequence of your alteration or modification, etc. of the document templates
or other originally provided materials, then and in that event, you agree to indemnify enKap, Inc. for such claims, and for any attorney’s fees expended by enKap, Inc. in connec-
tion with defense of same.

© copyright 2010 enKap